Tumor Necrosis Factor-α in Serum of Patients with Inflammatory Bowel Disease as Measured by a Highly Sensitive Immuno-PCR (original) (raw)

Tumor necrosis factor-alpha serum level in assessment of disease activity in inflammatory bowel diseases

PubMed, 2013

Altered immunoregulatory profile during anti-tumour necrosis factor treatment of patients with inflammatory bowel disease

Sarah Thunberg

Clinical & Experimental Immunology, 2012

View PDFchevron_right

Localization of TNF alpha in ileocolonic biopsies of patients with inflammatory bowel disease

Tiziana Salviato

Annals of Diagnostic Pathology, 2019

View PDFchevron_right

Review: Local Tumor Necrosis Factor-α Inhibition in Inflammatory Bowel Disease

Henderik Frijlink

Pharmaceutics

View PDFchevron_right

Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients

Hans Herfarth

Inflammatory Bowel Diseases, 2007

View PDFchevron_right

Effectiveness of anti-tumour necrosis factor-α therapy in Danish patients with inflammatory bowel diseases

Julie Galsgaard

Danish medical journal, 2015

View PDFchevron_right

Association of tumor necrosis factor-α and -β gene polymorphisms in inflammatory bowel disease

Misbahul Arfin

Journal of Inflammation Research, 2016

View PDFchevron_right

Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD

Amado Salvador Peña

Clinical and Experimental Immunology, 2007

View PDFchevron_right

Tumour necrosis factor and inflammatory bowel disease

Keith Gardiner

British Journal of Surgery, 1997

View PDFchevron_right

Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn's disease

Christian D Muller

Gut, 1996

View PDFchevron_right

Utility of serum TNF-α, infliximab trough level, and antibody titers in inflammatory bowel disease

Anita Bálint, Molnar Tamas

World journal of gastroenterology : WJG, 2014

View PDFchevron_right

Transmembrane TNF-α Density, but not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease

vu nguyen

Clinical and Translational Gastroenterology, 2017

View PDFchevron_right

Tumor necrosis factor-?, interleukin-1?, and interleukin-6 expression in inflammatory bowel disease

Anders Waage

Digestive Diseases and Sciences, 1992

View PDFchevron_right

Plasma histamine and tumour necrosis factor-alpha levels in Crohn's disease and ulcerative colitis at various stages of disease

Eckhart Hahn

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2015

View PDFchevron_right

Tumor Necrosis Factor Alpha in Ulcerative Colitis and Diverticular Disease Associated Colitis

Enzo Ierardi

Endocrine‚ Metabolic & Immune Disorders-Drug Targets, 2007

View PDFchevron_right

TNF-alpha-Converting Enzyme Activity in Colonic Biopsy Specimens from Patients with Inflammatory Bowel Disease Revealed by mRNA and in Vitro Assay

C. Ellervik

Annals of the New York Academy of Sciences, 1999

View PDFchevron_right

Tumor Necrosis Factor-α, Fecal Calprotectin, and Disease Activity in Inflammatory Bowel Disease Patients

Luciana Rotty

Open Access Macedonian Journal of Medical Sciences

View PDFchevron_right

Mucosal gene expression changes induced by anti‐TNF treatment in inflammatory bowel disease patients

Elena Milanesi

Drug Development Research

View PDFchevron_right

Tumor Necrosis Factor’s Pathway in Crohn’s Disease: Potential for Intervention

Fabio Cominelli

International Journal of Molecular Sciences, 2021

View PDFchevron_right

Altered pattern of tumor necrosis factor-alpha production in peripheral blood monocytes from Crohn's disease

Anna Bianco

World journal of gastroenterology, 2016

View PDFchevron_right

Immunohistochemistry Study of Expression of TNF-α, TRAF-1, and TRAF-2 in Patients Suffer from Ulcerative Colitis

IJAR Indexing

View PDFchevron_right

Antibodies Against Tumor Necrosis Factor (TNF) Induce T-Cell Apoptosis in Patients With Inflammatory Bowel Diseases via TNF Receptor 2 and Intestinal CD14+ Macrophages

Hermann Kessler

Gastroenterology, 2011

View PDFchevron_right

Efficacy of anti-TNF-alpha monoclonal antibodies in inflammatory bowel disease treatment

Jean-Marie Reimund

International Journal of Interferon, Cytokine and Mediator Research, 2013

View PDFchevron_right

Tumour necrosis factor superfamily members in the pathogenesis of inflammatory bowel disease

Zbigniew Kmieć

Mediators of inflammation, 2014

View PDFchevron_right

An increase in serum tumour necrosis factor-α during anti-tumour necrosis factor-α therapy for Crohn's disease – A paradox or a predictive index?

Natasza Czepulis

Digestive and Liver Disease, 2016

View PDFchevron_right

The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study

Daniel Sussman

Gut, 2015

View PDFchevron_right

Role of Tumor Necrosis Factor-Alpha (C-863A) Polymorphism in Pathogenesis of Inflammatory Bowel Disease in Northern India

Pravin Kesarwani

Journal of Gastrointestinal Cancer, 2011

View PDFchevron_right

Tumor Necrosis Factor-α in Serum of Patients with Inflammatory Bowel Disease as Measured by a Highly Sensitive Immuno-PCR (original) (raw)

Related papers